Suppr超能文献

墨西哥南部慢性胃炎患者中克拉霉素耐药性及幽门螺杆菌毒力基因型的流行情况

Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis.

作者信息

Alarcón-Millán Judit, Fernández-Tilapa Gloria, Cortés-Malagón Enoc Mariano, Castañón-Sánchez Carlos Alberto, De Sampedro-Reyes José, Cruz-Del Carmen Iván, Betancourt-Linares Reyes, Román-Román Adolfo

机构信息

Laboratorio de Investigación en Bacteriología, Unidad Académica de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, México.

Laboratorio de Investigación Clínica, Unidad Académica de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, México.

出版信息

Infect Genet Evol. 2016 Oct;44:190-198. doi: 10.1016/j.meegid.2016.06.044. Epub 2016 Jun 26.

Abstract

In developing countries, clarithromycin resistance and frequency of re-infection are factors that contribute to high prevalence of Helicobacter pylori infection. The aim of this research was determine the prevalence of clarithromycin resistance and its relation with A2142G, A2142C and A2143G mutations in the domain V of the 23S rRNA gene of H. pylori isolates in patients from Southern Mexico with chronic gastritis. Another purpose of this work was to study the prevalence of virulent genotypes and distribution of resistant strains according to the vacA/cagA/babA2 H. pylori genotypes. One hundred forty-four patients with chronic gastritis were studied. Forty-five H. pylori strains were isolated and clarithromycin susceptibility was determined by the disk-diffusion method. The 82.2% of the strains had the combination of alleles vacA s1 m1 and the cagA gene was detected in 77.8% and 40% of the strains were babA2 positive. The vacA s1 m1 genotype was detected more frequently in cagA(+) strains, vacA s1m1/cagA(+)/babA2(-) genotype was more frequent than vacA s1m1/cagA(+)/babA2(+), 37.8% and 33.3%, respectively. Eight strains were clarithromycin resistant, in three of these, point mutations were identified, but only in one strain the A2143G mutation associated with clarithromycin resistance was found. Other point mutations (A1821G, G1826A, T1830C, A2089G, T1600C, C1601T, C1602T, T1610C, A1611C and T1633G) that have not been associated with clarithromycin resistance were identified. The highest proportion of resistant strains was vacA s1m1/cagA(+) (62.5%). In patients from southern Mexico with chronic gastritis, the prevalence of clarithromycin resistance is within internationally accepted range (17.8%) and allows continued use of triple therapy for H. pylori eradication. However, it is necessary to monitor the evolution of clarithromycin resistance in this area. The largest proportion of resistant H. pylori strains is not harboring the A2142G, A2142C and A2143G mutations in the 23S rRNA gene (87.5%). The vacA s1m1/cagA(+) genotype was the most prevalent and among clarithromycin-resistant strains, this was the predominant.

摘要

在发展中国家,克拉霉素耐药性和再感染频率是导致幽门螺杆菌感染高流行率的因素。本研究的目的是确定墨西哥南部患有慢性胃炎患者的幽门螺杆菌分离株中克拉霉素耐药性的流行率及其与23S rRNA基因V结构域中A2142G、A2142C和A2143G突变的关系。这项工作的另一个目的是根据幽门螺杆菌vacA/cagA/babA2基因型研究毒力基因型的流行率和耐药菌株的分布。对144例慢性胃炎患者进行了研究。分离出45株幽门螺杆菌菌株,采用纸片扩散法测定克拉霉素敏感性。82.2%的菌株具有vacA s1 m1等位基因组合,77.8%的菌株检测到cagA基因,40%的菌株babA2呈阳性。vacA s1 m1基因型在cagA(+)菌株中检出频率更高,vacA s1m1/cagA(+)/babA2(-)基因型比vacA s1m1/cagA(+)/babA2(+)更常见,分别为37.8%和33.3%。8株对克拉霉素耐药,其中3株鉴定出点突变,但仅在1株中发现与克拉霉素耐药相关的A2143G突变。还鉴定出其他与克拉霉素耐药无关的点突变(A1821G、G1826A、T1830C、A2089G、T1600C、C1601T、C1602T、T1610C、A1611C和T1633G)。耐药菌株比例最高的是vacA s1m1/cagA(+)(62.5%)。在墨西哥南部患有慢性胃炎的患者中,克拉霉素耐药率在国际公认范围内(17.8%),这使得三联疗法仍可继续用于根除幽门螺杆菌。然而,有必要监测该地区克拉霉素耐药性的演变。大部分耐药幽门螺杆菌菌株在23S rRNA基因中未携带A2142G、A2142C和A2143G突变(87.5%)。vacA s1m1/cagA(+)基因型最为普遍,在克拉霉素耐药菌株中,这是主要的基因型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验